Page 24 - Journal of Special Operations Medicine - Summer 2015
P. 24

three diagnoses can be treated similarly with topical cor-  Scalp psoriasis may require a keratolytic in the form of
          ticosteroids and emollients .7,8                   a medicated shampoo. Either coal tar or salicylic acid
                                                             shampoo can be used daily in addition to a topical cor-
          Tinea infection, contact dermatitis, and atopic dermati-  ticosteroid; however, salicylic acid provides  improved
                                                                                  16
          tis can all have pruritic erythematous lesions with over-  scalp plaque resolution.  Many patients benefit from
          lying scale. However, both atopic dermatitis and tinea   alternating coal tar shampoo one day followed by sali-
          infection typically favor the flexural surfaces rather than   cylic acid the next.
          extensor surfaces. Additionally, microscopic  examina-
          tion with potassium hydroxide often reveals fungal el-  If a patient has an inadequate response to topical therapy
          ements in a tinea infection. Differentiation of contact   alone, phototherapy is a good addition in the deployed
          dermatitis often requires a compelling history and will   setting. Although controlled ultraviolet B (UVB), UVA,
          have a distribution  that corresponds to the areas of   or UV laser treatments are preferred and more effica-
          exposure.                                          cious, a sunbathing/tanning recommendation by a health
                                                             care provider can be used while deployed.  These rec-
                                                                                                  7,8
          Characteristic psoriatic lesions are well-demarcated ery-  ommendations should be used for 2 h/d between 10:00
          thematous plaques with hyperkeratotic silver scale that   and 14:00, and the patient should be instructed to keep
          can have local (elbows, knees, scalp, dorsal hands, glu-  all uninvolved areas covered by clothing. Tanning is con-
          teal cleft) or widespread distribution. The lesions may   traindicated if the patient has a history of skin cancer,
          have a positive Auspitz sign, where bleeding will occur   atypical nevi, or is not capable of tanning, i.e. Fitzpatrick
          with minor skin trauma as the scale is displaced. Com-  Skin Type 1 or has had multiple sunburns in the past. 8
          mon nail findings in psoriatic patients are pitting, ony-
          cholysis, and oil spots.                           Numerous  systemic  medications  are  available  for
                                                             patients that are resistant to outlined topical or UV
                                                             regimen; however, these options should not be initi-
          Treatments
                                                             ated in the  deployed setting. It is especially impor-
          Mild psoriasis can  often be controlled  with topical   tant to avoid systemic corticosteroids, due to the high
          agents alone. In contrast, moderate to severe psoriasis   probability of a severe psoriatic flare upon cessation.
          may require  the adjunct of phototherapy and  and/or   Targeted immune modulators: methotrexate, anti-
          systemic medications. It is also important to consider   TNF1 blockers, cyclosporine, can significantly alter
          the removal of possible triggers such as medications.  the disease course of psoriasis; however, they should
                                                             not be used while deployed, due to the monitoring re-
          The mainstay of topical therapy includes vitamin D   quired and the increased risk of infection. Specifically
          analogues and topical corticosteroids. Most vitamin D   targeted immune therapy can predispose  patients
          analogues can be used twice daily and are provided in   to streptococcal pneumonia, and  Mycobacterium
          multiple formulations to assist with medication deliv-  tuberculosis, hepatitis C virus, HIV, leishmaniasis,
                                                                                      17
          ery.  The  weekly  dose  of  vitamin  D  analogues  should   and Strongyloides infections.  While active tuberculo-
          not exceed 100g/wk and vitamin D analogues should be   sis cases attributed to infection acquired in Iraq and
          avoided in patients who have a history of hypercalcemia   Afghanistan have been negligible to date, there have
          or could likely develop it in the future. While vitamin D   been  increased rates of  leishmaniasis (0.23% of de-
          analogues are helpful, their efficacy is limited when used   ployed ground forces). 18
          as monotherapy.
                                                             All possible triggers should be investigated and then re-
          Topical corticosteroids can be used alone or in conjunc-  moved or mitigated, if possible. This includes a rapid
          tion with other agents such as vitamin d analogues or   group A  Streptococcus  titer, throat culture, and rapid
          coal tar. High potency corticosteroids (Class 1 or Class   HIV test; counseling about alcohol consumption, smok-
          2), and a combination of potent corticosteroids and vita-  ing  cessation,  and  stress  reduction;  and  investigation
                                           16
          min D analogues, are very efficacious.  Multiple deliv-  and then cessation of provoking medications.
          ery vehicles exist. Ointments typically penetrate the best
          and have the most potency within in a class, followed by   Conclusion
          creams, gels, and solution. It is important to simplify the
          patient’s topical routines while still limiting the applica-  Multiple trigger events for psoriasis are present in the
          tion of potent steroids the face, groin, and axillae. There   perideployment period for a genetically predisposed in-
          may be limited pharmacologic variety in the deployed   dividual. A trial of conservative management with trigger
          setting; if the appropriate vehicle is unavailable, topical   removal is appropriate. However, with limited resources,
          steroids can be occluded with clear wrap or dressings   taking advantage of any additional foreign or intermili-
          such as tegaderm or telfa to increase potency.     tary services and alternate treatments, such as tanning/



          14                                    Journal of Special Operations Medicine  Volume 15, Edition 2/Summer 2015
   19   20   21   22   23   24   25   26   27   28   29